Long QT Syndrome and Other Channelopathies



Postmortem studies of exercise-related sudden death victims showed that in some cases no evidence for structural heart disease could be found.


Structural Heart Disease Competitive Sport Brugada Syndrome Syncopic Episode Catecholaminergic Polymorphic Ventricular Tachycardia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We would like to acknowledge Dr. David Huang and Dr. Helmut Klein for sharing with us clinical cases illustrating patients with inherited channelopathies and Betty Mycking for her assistance in data collection.


  1. 1.
    Tester DJ, Ackerman MJ. The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol 2006;21:166–72PubMedCrossRefGoogle Scholar
  2. 2.
    Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AAM. Sudden unexplained death. Heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005;112:207–13PubMedCrossRefGoogle Scholar
  3. 3.
    Lehnart SE, Ackerman MJ, Benson DW Jr, Brugada R, Clancy CE, Donahue JK, George AL Jr, Grant AO, Groft SC, January CT, Lathrop DA, Lederer WJ, Makielski JC, Mohler PJ, Moss A, Nerbonne JM, Olson TM, Przywara DA, Towbin JA, Wang LH, Marks AR. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation 2007;116:2325–45PubMedCrossRefGoogle Scholar
  4. 4.
    Goldenberg I, Moss AJ. Long QT syndrome. J Am Coll Cardiol 2008;51:2291–300PubMedCrossRefGoogle Scholar
  5. 5.
    Benito B, Brugada R, Brugada J, Brugada P. Brugada syndrome. Progress Cardiovasc Dis 2008;51:1–22CrossRefGoogle Scholar
  6. 6.
    Schimpf R, Borggrefe M, Wolpert C. Clinical and molecular genetics of the short QT syndrome. Curr Opin Cardiol 2008;23:192–8PubMedCrossRefGoogle Scholar
  7. 7.
    Napolitano C, Priori SG. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2007;4:675–8PubMedCrossRefGoogle Scholar
  8. 8.
    Marcus FI. Depolarization/repolarization, electrocardiographic abnormalities, and arrhythmias in cardiac channelopathies. J Electrocardiol 2005;38(Suppl. 4):60–3PubMedCrossRefGoogle Scholar
  9. 9.
    Antzelevitch C. Heterogeneity and cardiac arrhythmias: an overview. Heart Rhythm 2007;4:964–72PubMedCrossRefGoogle Scholar
  10. 10.
    Boussy T, Paparella G, de Asmundis C, Sarkozy A, Chierchia GB, Brugada J, Brugada R, Brugada P. Genetic basis of ventricular arrhythmias. Cardiol Clin 2008;26(3):335–53PubMedCrossRefGoogle Scholar
  11. 11.
    Moss AJ, Schwartz PJ. Sudden death and the idiopathic long QT syndrome. AM J Med 1979;66:6PubMedCrossRefGoogle Scholar
  12. 12.
    Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E. The long QT syndrome: a prospective international study. Circulation 1985;71:17–21PubMedCrossRefGoogle Scholar
  13. 13.
    Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 1991;84:1136–44PubMedCrossRefGoogle Scholar
  14. 14.
    Jervell, FL-N. Congenital deal-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957;54:59–68PubMedCrossRefGoogle Scholar
  15. 15.
    Romano C, Gemme G, Pongiglione R. Rare cardiac arrhythmias of the pediatric age. Ii. Syncopal attacks due to paroxysmal ventricular fibrillation (Presentation of 1st case in Italian pediatric literature). Clin Pediatr (Bologna) 1963;45:656–83Google Scholar
  16. 16.
    Ward OC. A new familial cardiac syndrome in children. J Ir Med Assoc 1964;54:103–6PubMedGoogle Scholar
  17. 17.
    Tester DJ, Will ML, Haglund CM, Ackerman MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2005;2:507–17PubMedCrossRefGoogle Scholar
  18. 18.
    Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000;102:1178–85PubMedCrossRefGoogle Scholar
  19. 19.
    Napolitano C, Priori SG, Schwartz PJ, et al. Genetic testing in the long QT syndrome. Development and validation of an efficient approach to genotyping in clinical practice. JAMA 2005;294:2975–80PubMedCrossRefGoogle Scholar
  20. 20.
    Moss AJ, Kass RS. Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest 2005;115:2018–24PubMedCrossRefGoogle Scholar
  21. 21.
    Zareba W, Moss AJ, Schwartz PJ, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998;339:960–5PubMedCrossRefGoogle Scholar
  22. 22.
    Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999;99:529–33PubMedCrossRefGoogle Scholar
  23. 23.
    Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003;348:1866–74PubMedCrossRefGoogle Scholar
  24. 24.
    Hobbs JB, Peterson DR, Moss AJ, et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 2006;296:1249–54PubMedCrossRefGoogle Scholar
  25. 25.
    Sauer AJ, Moss AJ, McNitt S, et al. Long QT syndrome in adults. J Am Coll Cardiol 2007;49:329–37PubMedCrossRefGoogle Scholar
  26. 26.
    Vincent GM, Timothy KW, Leppert M, et al. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med 1992;327:846–52PubMedCrossRefGoogle Scholar
  27. 27.
    Locati EH, Zareba W, Moss AJ, et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 1998;97:2237–44PubMedCrossRefGoogle Scholar
  28. 28.
    Zareba W, Moss AJ, Locati EH, et al. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol 2003;42:103–9PubMedCrossRefGoogle Scholar
  29. 29.
    Moss AJ, Shimizu W, Wilde AA, et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 2007;115:2481–9PubMedCrossRefGoogle Scholar
  30. 30.
    Goldenberg I, Moss AJ, Zareba W, et al. Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. J Cardiovasc Electrophysiol 2006;17:1169–71CrossRefGoogle Scholar
  31. 31.
    Kaufman ES, McNitt S, Moss AJ, Zareba W, Robinson JL, Hall WJ, Ackerman MJ, Benhorin J, Locati ET, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Risk of death in the long QT syndrome when a sibling has died. Heart Rhythm 2008;5(6):831–6Google Scholar
  32. 32.
    Schwartz PJ, Zaza A, Locati E, Moss AJ. Stress and sudden death. The case of the long QT syndrome. Circulation 1991;83(Suppl. II):II71–80Google Scholar
  33. 33.
    Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103:89–95PubMedCrossRefGoogle Scholar
  34. 34.
    Ackerman MJ, Tester DJ, Porter CJ. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin Proc 1999;74:1088–94PubMedCrossRefGoogle Scholar
  35. 35.
    Moss AJ, Robinson JL, Gessman L, et al. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol 1999;84:876–9PubMedCrossRefGoogle Scholar
  36. 36.
    Choi G, Kopplin LJ, Tester DJ, Will ML, Haglund CM, Ackerman MJ. Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syncopes. Circulation 2004;110:2119–24PubMedCrossRefGoogle Scholar
  37. 37.
    Ott P, Marcus FI, Moss AJ. Ventricular fibrillation during swimming in a patient with long QT syndrome. Circulation 2002;106:521–2PubMedCrossRefGoogle Scholar
  38. 38.
    Ackerman MJ, Porter BJ. Identification of a family with inherited Long QT syndrome after a pediatric near drowning. Pediatrics 1998;101:306–8PubMedCrossRefGoogle Scholar
  39. 39.
    Batra AS, Silka MJ. Mechanism of sudden cardiac arrest while swimming in a child with the prolonged QT syndrome. J Pediatr 2002;141:283–4PubMedCrossRefGoogle Scholar
  40. 40.
    Lunetta P, Levo A, Laitinen PJ, Fodstad H, Kontula A, Sajantila A. Molecular screening of selected long QT syndrome (LQTS) mutations in 165 consecutive bodies found in water. Int J Legal Med 2003;117;115–7PubMedCrossRefGoogle Scholar
  41. 41.
    Katagiri-Kawade M, Ohe T, Arakaki Y, Kurita T, Shimizu W, Kamiya T, Orii T. Abnormal response to exercise, face immersion, and isoproterenol in children with the long QT syndrome. Pacing Clin Electrophysiol 1995;18(Pt 1):2128–34PubMedCrossRefGoogle Scholar
  42. 42.
    Viskin S, Rosovski U, Sands AJ, Chen E, Kistler PM, Kalman JM, Rodriguez Chavez L, Iturralde Torres P, Cruz FFE, Centurion OA, Fujiki A, Maury P, Chen X, Krahn AD, Roithinger F, Zhang L, Vincent GM, Zeltser D. Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm 2005;2:569–74PubMedCrossRefGoogle Scholar
  43. 43.
    Moss AJ, Robinson JL. Long QT syndrome. Heart Dis Stroke 1992;1:309–14PubMedGoogle Scholar
  44. 44.
    Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92:2929–34PubMedCrossRefGoogle Scholar
  45. 45.
    Zhang L, Timothy KW, Vincent GM, et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 2000;102:2849–55PubMedCrossRefGoogle Scholar
  46. 46.
    Zareba W. Genotype-specific patterns in long QT syndrome. J Electrocardiol 2006;39:S101–6PubMedCrossRefGoogle Scholar
  47. 47.
    Priori SG, Napolitano C, Schwartz PJ, et al. Association of long QT syndrome loci and cardiac events among patients treated with β-blockers. JAMA 2004;292:1341–4PubMedCrossRefGoogle Scholar
  48. 48.
    Zareba W, Moss AJ, le Cessie S, Locati EH, Robinson JL, Hall WJ, Andrews ML. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol 1995;26:1685–91PubMedCrossRefGoogle Scholar
  49. 49.
    Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 2000;101:616–23PubMedCrossRefGoogle Scholar
  50. 50.
    Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 1996;78:703–6PubMedCrossRefGoogle Scholar
  51. 51.
    Zareba W, Moss AJ, Daubert JP, et al. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003;14:337–41PubMedCrossRefGoogle Scholar
  52. 52.
    Daubert JP, Zareba W, Rosero SZ, Budzikowski A, Robinson JL, Moss AJ. Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am Heart J 2007;153(Suppl. 4):53–8PubMedCrossRefGoogle Scholar
  53. 53.
    Moss AJ, McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med 1971;285:903–4PubMedCrossRefGoogle Scholar
  54. 54.
    Schwartz PJ, Priori SG, Cerrone M, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation 2004;109:1826–33PubMedCrossRefGoogle Scholar
  55. 55.
    Algra A, Tjissen JG, Roelandt Pool J, Lubsen J. QT interval variables from 24 hour electrocardiography and the two-year risk of sudden death. Br Heart J 1993;70:43–8PubMedCrossRefGoogle Scholar
  56. 56.
    Gussak I, Brugada P, Brugada J, Wright RS, Kopecky SL, Chaitman BR, Bjerregaard P. Idiopathic short QT interval: a new clinical syndrome? Cardiology 2000;94:99–102PubMedCrossRefGoogle Scholar
  57. 57.
    Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R, et al. Short QT syndrome: a familial cause of sudden death. Circulation 2003;103:965–70CrossRefGoogle Scholar
  58. 58.
    Giustetto C, Di Monte F, Wolpert C, Borggrefe M, Schimpf R, Sbragia P, Leone G, Maury P, Anttonen O, Haissaguerre M, Gaita F. Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J 2006;27:2440–7PubMedCrossRefGoogle Scholar
  59. 59.
    Brugada R, Hong K, Dumaine R, Cordeiro J, Gaita F, Borggrefe M, Menendez TM, Brugada J, Pollevick GD, Wolpert C, Burashnikov E, Matsuo K, Wu YS, Guerchicoff A, Bianchi F, Giustetto C, Schimpf R, Brugada P, Antzelevitch C. Sudden death associated with short QT syndrome linked to mutations in HERG. Circulation 2004;109:30–5PubMedCrossRefGoogle Scholar
  60. 60.
    Bellocq C, van Ginneken AC, Bezzina CR, Alders M, Escante D, Mannens MM, Baro I, Wilde AA. Mutation in KCNQ1 gene adding to the short QT interval syndrome. Circulation 2004;109:2394–7PubMedCrossRefGoogle Scholar
  61. 61.
    Priori SG, Pandit SV, Rivolta I, Berenfed O, Ronchetti E, Dhamoon A, Napolitano C, Anumonwo J, di Barleta MR, Gudapakkam S, Bosi G, Stramba-Badiale M, Jalife J. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 2005;96:800–7PubMedCrossRefGoogle Scholar
  62. 62.
    Antzelevitch C, Pollevick GD, Cordeiro JM, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007;115:442–9PubMedCrossRefGoogle Scholar
  63. 63.
    Schimpf R, Bauersfeld U, Gaita F, Wolpert C. Short QT syndrome: successful prevention of sudden death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm 2005;2:416–7PubMedCrossRefGoogle Scholar
  64. 64.
    Schimpf R, Wolpert C, Bianchi F, Giustetto C, Gaita F, Bauersfeld U, et al. Congenital short QT syndrome and implantable cardioverter defibrillator: inherent risk for inappropriate shock delivery. J Cardiovasc Electrophysiol 2003;14:1273–7PubMedCrossRefGoogle Scholar
  65. 65.
    Gaita F, Guistetto C, Bianchi F, Schimpf R, Haissaguerre M, Calo L, et al. Short QT syndrome; pharmacological treatment. J Am Coll Cardiol 2004;43:1494–9PubMedCrossRefGoogle Scholar
  66. 66.
    Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391–6PubMedCrossRefGoogle Scholar
  67. 67.
    Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2005;2(4):429–40PubMedCrossRefGoogle Scholar
  68. 68.
    Hermida JS, Lemoisne JL, Aoun FB, Jarry G, Rey JL, Quiret JC. Prevalence of the Brugada syndrome in an apparently healthy population. Am J Cardiol 2000;86:91–4PubMedCrossRefGoogle Scholar
  69. 69.
    Shimizu W, Matsuo K, Kokubo Y, Satomi K, Kurita T, Noda T, Nagaya N, Suyama K, Aihara N, Kamakura S, Inamoto N, Akahoshi M, Tomoike H. Sex hormone and gender difference – role of testosterone on male predominance in Brugada syndrome. J Cardiovasc Electrophysiol 2007;18:415–21PubMedCrossRefGoogle Scholar
  70. 70.
    James AF, Choisy SC, Hancox JC. Recent advances in understanding sex differences in cardiac repolarization. Prog Biophys Mol Biol 2007;94(3):265–319PubMedCrossRefGoogle Scholar
  71. 71.
    Antzelevitch C. Genetic basis of Brugada syndrome. Heart Rhythm. 2007;4:756–7PubMedCrossRefGoogle Scholar
  72. 72.
    Brugada R, Brugada P, Brugada J. Electrocardiogram interpretation and class I blocker challenge in Brugada syndrome. J Electrocardiol 2006;39(Suppl. 4):S115–8PubMedCrossRefGoogle Scholar
  73. 73.
    Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA, Brugada P. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101(5):510–5PubMedCrossRefGoogle Scholar
  74. 74.
    Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996;27(5):1061–70PubMedCrossRefGoogle Scholar
  75. 75.
    Antzelevitch C, Brugada R. Fever and Brugada syndrome. Pacing Clin Electrophysiol 2002;25:1537–9PubMedCrossRefGoogle Scholar
  76. 76.
    Mizumaki K, Fujiki A, Tsuneda T, Sakabe M, Nishida K, Sugao M, Inoue H. Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome. J Cardiovasc Electrophysiol 2004;15:667–73PubMedCrossRefGoogle Scholar
  77. 77.
    Bianco M, Bria S, Gianfelici A, Sanna N, Palmieri V, Zeppilli P. Does early repolarization in the athlete have analogies with the Brugada syndrome? Eur Heart J 2001;22:504–10PubMedCrossRefGoogle Scholar
  78. 78.
    Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, Bloise R, Giustetto C, De Nardis R, Grillo M, Ronchetti E, Faggiano G, Nastoli J. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;105: 1342–7PubMedCrossRefGoogle Scholar
  79. 79.
    Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73–8PubMedCrossRefGoogle Scholar
  80. 80.
    Brugada J, Brugada R, Brugada P. Pharmacological and device approach to therapy of inherited cardiac diseases associated with cardiac arrhythmias and sudden death. J Electrocardiol 2000;33(Suppl):41–7PubMedCrossRefGoogle Scholar
  81. 81.
    Alings M, Dekker L, Sadée A, Wilde A. Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin Electrophysiol 2001;24(9 Pt 1):1420–2PubMedCrossRefGoogle Scholar
  82. 82.
    Tanaka H, Kinoshita O, Uchikawa S, Kasai H, Nakamura M, Izawa A, Yokoseki O, Kitabayashi H, Takahashi W, Yazaki Y, Watanabe N, Imamura H, Kubo K. Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome. Pacing Clin Electrophysiol 2001;24(8 Pt 1):1293–4PubMedCrossRefGoogle Scholar
  83. 83.
    Sarkozy A, Boussy T, Kourgiannides G, Chierchia GB, Richter S, De Potter T, Geelen P, Wellens F, Spreeuwenberg MD, Brugada P. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J 2007;28:334–44PubMedCrossRefGoogle Scholar
  84. 84.
    Mohamed U, Napolitano C, Priori SG. Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 2007;18:791–7PubMedCrossRefGoogle Scholar
  85. 85.
    Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106(1):69–74PubMedCrossRefGoogle Scholar
  86. 86.
    Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995;91:1512–9PubMedCrossRefGoogle Scholar
  87. 87.
    Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y, Saito A, Kurosaki K, Jouo K, Koujiro M, Konishi S, Matsuoka S, Oono T, Hayakawa S, Miura M, Ushinohama H, Shibata T, Niimura I. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 2003;89:66–70PubMedCrossRefGoogle Scholar
  88. 88.
    Zipes DP, Ackerman MJ, Estes III M, Grant AO, Myerburg R, Van Hare G. 36th Bethesda Conference. Task Force 7: Arrhythmias. J Am Coll Cardiol 2005;45:1354–63PubMedCrossRefGoogle Scholar
  89. 89.
    Pelliccia A, Fagard R, Bjørnstad HH, Anastassakis A, Arbustini E, Assanelli D, Biffi A, Borjesson M, Carrè F, Corrado D, Delise P, Dorwarth U, Hirth A, Heidbuchel H, Hoffmann E, Mellwig KP, Panhuyzen-Goedkoop N, Pisani A, Solberg EE, van-Buuren F, Vanhees L, Blomstrom-Lundqvist C, Deligiannis A, Dugmore D, Glikson M, Hoff PI, Hoffmann A, Hoffmann E, Horstkotte D, Nordrehaug JE, Oudhof J, McKenna WJ, Penco M, Priori S, Reybrouck T, Senden J, Spataro A, Thiene G; Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology; Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(14):1422–45PubMedCrossRefGoogle Scholar
  90. 90.
    Maron BJ, Chaitman BR, Ackerman MJ, Bayes de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, Estes NA 3rd, Araujo CG, LIang DH, Mitten MJ, Myerburg RJ, Peliccia A, Thompson PD, Towbin JA, Van Camp SP. Working Groups of the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention; Councils on Clinical and Cardiovascular Disease in the Young. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004;109:2807–16PubMedCrossRefGoogle Scholar
  91. 91.
    Heidbuchel H, Corrado D, Biffi A, Hoffmann E, Panhuyzen-Goedkoop N, Hoogsteen J, Delise P, Hoff PI, Peliccia A. Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Eur J Cardiovasc Prev Rehabil 2006;13:676–86PubMedCrossRefGoogle Scholar
  92. 92.
    Lampert R, Cannom D, Olshansky B. Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of Heart Rhythm Society Members. J Cardiovasc Electrophysiol 2006;17:11–5PubMedCrossRefGoogle Scholar
  93. 93.
    Maron BJ, Zipes DP. It is not prudent to allow all athletes with implantable cardioverter defibrillators to participate in all sports. Heart Rhythm 2008;5:864–6PubMedCrossRefGoogle Scholar
  94. 94.
    Lampert R, Cannom D. Sports participation for athletes with implantable cardioverter-defibrillators should be an individualized risk-benefit decision. Heart Rhythm 2008;5:861–3PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Heart Research Follow-up ProgramUniversity of Rochester Medical CenterRochesterUSA

Personalised recommendations